Drug Eluting Permanent Left Ventricular (Lv) Pacemaker Electrode
The Drug Eluting Permanent Left Ventricular (LV) Pacemaker Electrode is a drug-eluting implantable cardiac pacing lead used with compatible cardiac resynchronization therapy (CRT) devices to deliver pacing pulses to the left ventricle of the heart, with a drug-eluting coating intended to reduce local inflammation or tissue reaction at the electrode tip. Classified as FDA Class 3 requiring Premarket Approval (PMA) due to the significant risks of an implanted, life-sustaining cardiac device incorporating a drug component, reviewed by the Cardiovascular panel. The product code is OJX. It is flagged as both an implant and a life-sustaining/life-supporting device.
Research product code OJX in seconds
The Research Assistant summarizes clearances, adverse event trends and regulation context for a product code — and cites every record.
Free to try · every answer cites its records
Basic Information
- Product Code
- OJX
- Device Class
- FDA class 3
- Medical Specialty
- Unknown
- Review Panel
- CV
- Submission Type
- 2
Device Characteristics
Definition
Drug eluting permanent lv pacemaker electrodes are used with compatible cardiac rhythm therapy (crt) devices to deliver pacing pulses to the heart.
FEI Numbers
This FDA classification entry is associated with 21 FEI numbers. Click on an entry to view related FDA registrations.
Registration Numbers
This FDA classification entry is associated with 21 registration numbers. Click on an entry to view related FDA registrations.